7 results
8-K
EX-99.1
PIRS
Pieris Pharmaceuticals Inc
28 Feb 20
Regulation FD Disclosure
10:59am
fitness tumor TME Enhances anti-tumor activity across innate and adaptive Promoting a sustainable immune response anti-tumor immunity3 4-1BB Agonism
8-K
EX-99.1
s7im1lv
18 Dec 14
Report of Independent Registered Public Accounting Firm
12:00am
8-K
EX-99.2
c37jehtwl71h s4aruek
18 Dec 14
Report of Independent Registered Public Accounting Firm
12:00am
- Prev
- 1
- Next